Compugen Ltd. (CGEN)

CIK 0001119774 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —
FY-2023 —
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
—
Statements
Consolidated Balance Sheets
—
Consolidated Balance Sheets (P)
—
Consolidated Statements of Comprehensive Loss
—
Consolidated Statements of Comprehensive Profit (loss)
—
Statements of Changes In Shareholders' Equity
—
Consolidated Statements of Cash Flows
—
Notes
Commitments and Contingencies
—
Cybersecurity Risk Management and Strategy Disclosure
—
Fair Value Measurements
—
Financial and Other Income, Net
—
General
—
Geographic Information and Major Customers
—
Insider Trading Policies and Procedures
—
Leases
—
Losses Per Share
—
Marketable Securities
—
Other Accounts Payable and Accrued Expenses
—
Other Accounts Receivable and Prepaid Expenses
—
Pay Vs Performance Disclosure
—
Profit (loss) Per Share
—
Property and Equipment, Net
—
Related Party Balances and Transactions
—
Segments, Geographic Information and Major Customer Data
—
Shareholders' Equity
—
Significant Accounting Policies
—
Subsequent Events
—
Taxes On Income, Net
—